Immunotherapy following high-dose chemotherapy (HDCT) and peripheral blood progenitor cell transplantation (PBPCT) in the treatment of high-risk early breast cancer (HREBC) and metastatic breast cancer (MBC).
2000 ◽
Vol 25
(10)
◽
pp. 1047-1052
◽
2003 ◽
Vol 129
(6)
◽
pp. 361-366
◽
Keyword(s):
2001 ◽
Vol 28
(11)
◽
pp. 1023-1029
◽
1999 ◽
Vol 43
(1)
◽
pp. 8-12
◽
2015 ◽
Vol 8
(3)
◽
pp. 115-124
◽
1996 ◽
Vol 74
(12)
◽
pp. 2013-2017
◽
2000 ◽
Vol 9
(1)
◽
pp. 103-109
◽